Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03512509
Other study ID # B344
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 5, 2018
Est. completion date August 20, 2018

Study information

Verified date October 2018
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is a single-blind, randomised crossover study, investigating how a high glycaemic potato affects satiety in humans compared to a low glycaemic potato. This is done to shed further light on the discussion about whether potatoes with a high glycaemic index increases the risk of overweight and obesity and thus indirectly type 2 diabetes and cardiovascular disease.


Description:

The POSAT study follows a single-blinded randomized crossover design. Each subject will have two separate intervention days with at least a six-day washout period in between. On the two intervention days the subjects will be randomized into receiving a breakfast containing isocaloric amounts of either low or high GI potatoes. VAS will be measured 5 minutes before the meal, immediately after the meal is consumed and in intervals of 30 minutes thereafter until 2,5 hours after the initial meal. After this the subjects will be served a standardized homogenous ad libitum meal. The amount of food consumed will be registered. The subjects will be asked to fast for 8-10 hours prior to the trial days and abstain from vigorous physical activity and alcohol consumption for 2 days prior to each trial day. The trial will be conducted over a total of 8 days with 5-6 study subjects pr. trial day. The trial days will be spread out over a total of 2 weeks to allow for a 1-week washout period between trial days for each subject.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date August 20, 2018
Est. primary completion date April 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy men

- Body mass index (BMI) 18-27 kg/m2

- Age 18-40 years

- Signed informed consent

- Able to eat 500 grams of potato for breakfast

Exclusion Criteria:

- Chronic diseases as diabetes, cardiovascular diseases or other chronic metabolic diseases, which could affect the results.

- Use of daily prescription medicine (mild analgesics and antihistamines are allowed).

- Use of medicine or dietary supplements that can affect ones appetite one month before the start of the study.

- Smoking or have been smoking or using any nicotine products (gum or e-cigarette) within the last 3 months. Irregular smoking is allowed.

- Elite athletes defined as doing >10 hours of strenuous physical activity per week.

- Participation in other clinical studies <1 month before or during the study.

- Inability, physically or psychologically, to comply with the procedures required by the study protocol. Judged by the investigators.

- Any food allergies.

- Weight change of ±3 kg from screening to the trial has been conducted.

- Inability to complete the trial within 3 months after screening.

- Unable to fast 8-10 hours before the trial days.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low glycaemic potato
The Carisma potato variety is used as the low glycaemic index potato.
High glycaemic potato
The Arizona potato variety is used as the high glycaemic index potato.

Locations

Country Name City State
Denmark University of Copenhagen Frederiksberg

Sponsors (1)

Lead Sponsor Collaborator
Anne Birgitte Raben

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective satiety evaluation Visual Analogue Scale (100mm) filled out by subjects to describe satiety. 3 hours
Secondary Hunger, fullness, and prospective food consumption Visual Analogue Scale (100mm) filled out by subjects to describe hunger, fullness, and prospective food consumption. 3 hours
Secondary Energy consumed in Ad libitum meal Energy intake (kJ) meassured by weighing of food consumed during a ad libitum meal. 30 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2